Monthly information on share capital and company voting rights

Cellectis (CLLS) released its monthly information on share capital and voting rights under Article 223-16 of the French financial markets authority rules.

Rhea-AI Summary

Cellectis (CLLS) released its monthly information on share capital and voting rights under Article 223-16 of the French financial markets authority rules.

As of June 30, 2026, Cellectis reported 100,698,158 shares outstanding and a total of 105,551,650 voting rights on Euronext Growth.

Argus Jul 6 session

-0.30% close to close Open Argus

Details

News Market Reaction – CLLS

On Jul 6, the first trading day after this news, CLLS closed 0.30% below the previous close.

Data tracked by StockTitan Argus for the Jul 6 session.

Key Figures

Total shares outstanding: 100,698,158 shares Total voting rights: 105,551,650 voting rights Share price (pre-headline): $3.30 +1 more

Total shares outstanding

100,698,158 shares

As of June 30, 2026 on Euronext Growth

Total voting rights

105,551,650 voting rights

As of June 30, 2026 on Euronext Growth

Share price (pre-headline)

$3.30

Nasdaq, around publication time

Market capitalization

$301,834,443

Pre-headline market value

Historical Context

5 past events · Latest: Jun 25

5 events

1. Jun 25

   Shareholder meeting results

   24h Move

   -2.1%

   Reported adoption of resolutions 1–29 and rejection of resolution 30.

2. Jun 11

   Clinical trial data

   24h Move

   -2.8%

   Final Phase 1 lasme‑cel and preliminary eti‑cel efficacy and safety results.

3. Jun 09

   Regulatory designation

   24h Move

   +6.3%

   FDA RMAT designation for lasme‑cel in relapsed or refractory B‑ALL.

4. Jun 03

   Monthly capital update

   24h Move

   +1.9%

   Published May 31, 2026 share count and voting rights for Euronext Growth.

5. May 20

   AGM scheduling

   24h Move

   -3.8%

   Announced date, time and location of June 25, 2026 annual meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

isin code, voting rights, share capital, euronext growth

4 terms

isin code financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

voting rights financial

"Total number of voting rights"

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

share capital financial

"Total number of shares in the capital"

Share capital is the total amount of money a company raises by selling pieces of itself, called shares, to investors. It’s like a company’s savings from many owners, which helps fund its growth and operations. This money matters because it shows how much the company has raised from shareholders and how it’s financed its business.

euronext growth financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

Euronext Growth is a stock market for smaller, emerging companies that want to raise money and grow. It makes it easier for these companies to get listed and attract investors, similar to a training ground for future big businesses. This helps new companies develop and eventually become larger, more established firms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, July 02, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
06/30/2026	100,698,158	105,551,650

For further information on Cellectis, please contact:         

Media contacts:              
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93      
    
Investor Relations contact:           
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com 

Attachment

• Voting_Rights_PR_June_2026_EN

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Cellectis (CLLS) shares were outstanding on June 30, 2026?

On June 30, 2026, Cellectis reported 100,698,158 shares outstanding. According to Cellectis, this figure represents the total number of shares in its share capital listed on Euronext Growth at that month-end reporting date.

What was the total number of Cellectis (CLLS) voting rights as of June 30, 2026?

As of June 30, 2026, Cellectis reported 105,551,650 total voting rights. According to Cellectis, this voting-rights figure accompanies 100,698,158 shares outstanding on Euronext Growth, providing investors with updated governance and capital structure information.

On which market is Cellectis (CLLS) share capital and voting rights reported for June 30, 2026?

Cellectis reports its June 30, 2026 share capital and voting rights on Euronext Growth. According to Cellectis, the company provides this monthly disclosure in line with Article 223-16 of the French financial markets authority’s General Regulation.

Why does Cellectis (CLLS) publish monthly information on share capital and voting rights?

Cellectis publishes monthly share capital and voting-rights data to keep investors informed about its capital structure. According to Cellectis, this reporting follows Article 223-16 requirements from the French financial markets authority, enhancing transparency for Euronext Growth shareholders.

What identification code is used for Cellectis (CLLS) in the June 30, 2026 disclosure?

The June 30, 2026 disclosure identifies Cellectis with ISIN code FR0010425595. According to Cellectis, this ISIN uniquely labels its shares traded on Euronext Growth, helping investors and intermediaries track the company’s securities and related voting-rights information.